LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)
CUSIP: 514766104
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 37,253,000
- Total 13F shares
- 24,790,192
- Share change
- +389,068
- Total reported value
- $202,785,326
- Put/Call ratio
- 11%
- Price per share
- $8.18
- Number of holders
- 102
- Value change
- +$3,377,781
- Number of buys
- 49
- Number of sells
- 40
Quarterly Holders Quick Answers
What is CUSIP 514766104?
CUSIP 514766104 identifies LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 514766104:
Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Christopher S. Kiper |
3/4/5
|
Director, 10%+ Owner |
12%
|
4,481,329
|
$36,388,838 | — | 15 Jul 2025 | |
| WYNNEFIELD CAPITAL INC |
13F
|
Company |
13%
|
4,703,216
|
$34,615,669 | — | 30 Sep 2025 | |
| Legion Partners Asset Management, LLC |
13F
|
Company |
12%
|
4,461,823
|
$32,839,017 | — | 30 Sep 2025 | |
| Greenhaven Road Investment Management, L.P. |
13F
13D/G
|
Company |
9.8%
from 13D/G
|
3,694,832
|
$27,193,964 | — | 30 Sep 2025 | |
| 22NW Fund, LP |
13D/G
|
— |
7.5%
|
2,975,398
|
$20,768,278 | -$9,716,865 | 27 May 2025 | |
| 22NW, LP |
13F
|
Company |
0%
|
1,254
|
$20,147,121 | — | 30 Sep 2025 | |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,703,216
|
$19,283,185 | — | 03 Oct 2024 | |
| 325 CAPITAL LLC |
13F
|
Company |
5.8%
|
2,162,466
|
$15,915,750 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
5.1%
|
1,899,903
|
$15,541,966 | +$536,503 | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
1,622,769
|
$11,943,580 | — | 30 Sep 2025 | |
| David Capital Partners, LLC |
13D/G
|
— |
4.9%
|
1,803,000
|
$11,467,080 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
773,629
|
$5,695,500 | — | 30 Sep 2025 | |
| GRIZZLYROCK CAPITAL, LLC |
13F
|
Company |
2%
|
738,882
|
$5,438,172 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
709,699
|
$5,223,387 | — | 30 Sep 2025 | |
| Paul Josephs |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,983,328
mixed-class rows
|
$5,186,956 | — | 08 Jul 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
539,284
|
$3,969,130 | — | 30 Sep 2025 | |
| DCF Advisers, LLC |
13F
|
Company |
1.2%
|
452,000
|
$3,326,720 | — | 30 Sep 2025 | |
| James G. Hall |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
276,096
|
$2,876,920 | — | 01 Jun 2023 | |
| Ryan David Lake |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
936,691
mixed-class rows
|
$2,595,887 | — | 03 Sep 2025 | |
| Aron R. English |
3/4/5
|
10%+ Owner |
0.71%
|
264,180
|
$1,881,965 | -$9,870,744 | 23 May 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.64%
|
238,625
|
$1,756,279 | — | 30 Sep 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.5%
|
184,481
|
$1,357,780 | — | 30 Sep 2025 | |
| John D. Morberg |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
125,617
|
$1,308,929 | — | 18 Jan 2024 | |
| Nelson Obus |
3/4/5
|
Director |
0.37%
|
138,193
|
$1,122,140 | — | 15 Jul 2025 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.41%
|
151,700
|
$1,116,512 | — | 30 Sep 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.41%
|
150,909
|
$1,110,690 | — | 30 Sep 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.4%
|
148,190
|
$1,090,678 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.36%
|
135,205
|
$995,109 | — | 30 Sep 2025 | |
| Craig A. Barbarosh |
3/4/5
|
Director |
—
class O/S missing
|
88,073
|
$917,721 | — | 08 Jul 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.33%
|
122,983
|
$905,000 | — | 30 Sep 2025 | |
| Katrina Houde Lovas |
3/4/5
|
Director |
0.29%
|
109,412
|
$888,436 | — | 15 Jul 2025 | |
| Joshua Schechter |
3/4/5
|
Director |
0.29%
|
107,173
|
$870,255 | — | 15 Jul 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.31%
|
114,075
|
$839,592 | — | 30 Sep 2025 | |
| Jeffrey L. Edwards |
3/4/5
|
Director |
—
class O/S missing
|
79,667
|
$830,130 | — | 08 Jul 2024 | |
| Albert D. Bolles |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
72,883
|
$759,441 | — | 23 May 2022 | |
| Raymond H. Diradoorian |
3/4/5
|
Director |
—
class O/S missing
|
69,978
|
$729,171 | — | 08 Jul 2024 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
92,828
|
$683,214 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.24%
|
87,687
|
$645,376 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
84,863
|
$624,592 | — | 30 Sep 2025 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.23%
|
84,500
|
$621,920 | — | 30 Sep 2025 | |
| Tonia L. Pankopf |
3/4/5
|
Director |
—
class O/S missing
|
59,599
|
$621,022 | — | 04 Jun 2022 | |
| Nathaniel Calloway |
3/4/5
|
Director |
—
class O/S missing
|
58,069
|
$605,079 | — | 08 Jul 2024 | |
| Catherine A. Sohn |
3/4/5
|
Director |
—
class O/S missing
|
54,069
|
$563,399 | — | 04 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
66,752
|
$491,295 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.18%
|
66,272
|
$487,762 | — | 30 Sep 2025 | |
| Pale Fire Capital SE |
13F
|
Company |
0.17%
|
64,620
|
$475,603 | — | 30 Sep 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
61,800
|
$454,848 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
55,336
|
$407,273 | — | 30 Sep 2025 | |
| Humberto C. Antunes |
3/4/5
|
Director |
0.13%
|
47,060
|
$382,131 | — | 15 Jul 2025 | |
| Deborah D. Carosella |
3/4/5
|
Director |
—
class O/S missing
|
36,588
|
$381,247 | — | 04 Jun 2022 |
Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2025
As of 31 Dec 2025,
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,790,192 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., 325 CAPITAL LLC, BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, GRIZZLYROCK CAPITAL, LLC, and STATE STREET CORP.
This page lists
102
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
99
Q4 2025 holders
102
Holder diff
3
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.